Detalhe da pesquisa
1.
Long-Term Survival and Recurrence Patterns in Locally Advanced Esophageal Squamous Cell Carcinoma Patients with Pathologic Complete Response After Neoadjuvant Chemotherapy Followed by Surgery.
Ann Surg Oncol
; 2024 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38172446
2.
Pre-operative oil ingestion reduces the probability of thoracic duct trunk ligation during esophagectomy.
Dis Esophagus
; 36(6)2023 May 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36533426
3.
Discrimination of Malignant versus Benign Mediastinal Lymph Nodes Using Diffusion MRI with an IVIM Model.
Eur Radiol
; 28(3): 1301-1309, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28929210
4.
P21, COX-2, and E-cadherin are potential prognostic factors for esophageal squamous cell carcinoma.
Dis Esophagus
; 30(2): 1-10, 2017 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27868288
5.
CT Signs Can Predict Treatment Response and Long-Term Survival: A Study in Locally Advanced Esophageal Cancer with Preoperative Chemotherapy.
Ann Surg Oncol
; 22 Suppl 3: S1380-7, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25940570
6.
The survival predictive significance of HOXC6 and HOXC8 in esophageal squamous cell carcinoma.
J Surg Res
; 188(2): 442-50, 2014 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24525058
7.
Considerations for multidisciplinary management of synchronous primary breast cancer and primary lung cancer - Analysis of thirty-one patients.
Thorac Cancer
; 15(14): 1132-1137, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38572623
8.
Erlotinib versus gemcitabine plus cisplatin as neoadjuvant treatment of stage IIIA-N2 EGFR-mutant non-small-cell lung cancer: final overall survival analysis of the EMERGING-CTONG 1103 randomised phase II trial.
Signal Transduct Target Ther
; 8(1): 76, 2023 02 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36823150
9.
Malignant transformation of heterotopic pancreas as middle esophagus adenocarcinoma-A rare case report and comprehensive literature review.
Thorac Cancer
; 13(7): 1083-1087, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35253375
10.
Risk factors for early local lymph node recurrence of thoracic ESCC after McKeown esophagectomy.
Front Surg
; 9: 1043755, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36684130
11.
Genome-scale CRISPR activation screening identifies a role of ELAVL2-CDKN1A axis in paclitaxel resistance in esophageal squamous cell carcinoma.
Am J Cancer Res
; 9(6): 1183-1200, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31285951
12.
The identification of the ATR inhibitor VE-822 as a therapeutic strategy for enhancing cisplatin chemosensitivity in esophageal squamous cell carcinoma.
Cancer Lett
; 432: 56-68, 2018 09 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-29890208
13.
Increased HOXC6 expression predicts chemotherapy sensitivity in patients with esophageal squamous cell carcinoma.
Oncol Lett
; 14(4): 4835-4840, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-29085488
14.
Possible prediction of the response of esophageal squamous cell carcinoma to neoadjuvant chemotherapy based on gene expression profiling.
Oncotarget
; 7(4): 4531-41, 2016 Jan 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-26673820
15.
The equivalent efficacy of multiple operations for multiple primary lung cancer and a single operation for single primary lung cancer.
J Thorac Dis
; 8(5): 855-61, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-27162659
16.
Deregulated HOXB7 Expression Predicts Poor Prognosis of Patients with Esophageal Squamous Cell Carcinoma and Regulates Cancer Cell Proliferation In Vitro and In Vivo.
PLoS One
; 10(6): e0130551, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26076456
17.
[Up-regulation of HOXA13 in esophageal squamous cell carcinoma of stage IIa and its effect on the prognosis].
Zhonghua Wei Chang Wai Ke Za Zhi
; 12(1): 20-3, 2009 Jan.
Artigo
em Chinês
| MEDLINE | ID: mdl-19145497